Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06729021 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Predictive Value of Modified Caprini Score and D-Dimer in Managing Lower Limb Venous Thrombosis in Cardiothoracic Patients

Study acronym: DVT
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Jul 20, 2025 → Jul 20, 2027
See other at-risk trials from Al-Nahrain University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 20, 2025 to Jul 20, 2027 Show 4 more changesShow less
    • Study completion pushed from Jul 30, 2025 to Jul 30, 2027
    • Eligibility criteria expanded, about 10 words
    • Site contact updated
    • Publications: details revised at 12 of 16 entries
  2. Primary completion date: Apr 20, 2025 to Jul 20, 2025
    • Study completion date: May 1, 2025 to Jul 30, 2025
    v4
  3. Trial status: Not Yet Recruiting to Recruitingv3 Show 6 more changesShow less
    • Primary completion date: Feb 20, 2025 to Apr 20, 2025
    • Study completion date: Mar 1, 2025 to May 1, 2025
    • Start date changed from estimate of Dec 20, 2024 to Jan 20, 2025
    • Eligibility criteria shortened, about 12 words
    • Secondary endpoints: details revised at 1 of 2 entries
    • Site details revised
  4. Primary endpoints revised (3)
    • Secondary endpoints revised (2)
    • Study description expanded, about 16 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to evaluate the predictive efficacy of the Modified Caprini Risk Assessment Score and D-Dimer in identifying and managing lower extremity venous thrombosis (LEVT) among cardiothoracic surgery patients in Baghdad. The main questions it aims to answer are: Does combining the Modified Caprini Score with D-Dimer improve the accuracy of predicting lower extremity venous thrombosis (LEVT) compared to using each tool independently? Can these tools effectively guide clinical decisions for lower extremity venous thrombosis (LEVT) prevention and management in this patient population? Participants will: Undergo risk assessment for lower extremity venous thrombosis (LEVT) using the Modified Caprini Score and have their D-Dimer levels measured during their hospital stay. Be monitored for clinical outcomes, including confirmed lower extremity venous thrombosis (LEVT) incidence, need for anticoagulation therapy, and complications such as pulmonary embolism or recurrent thrombosis.
Trial Details
NCT Number NCT06729021
Lead Sponsor Al-Nahrain University
Conditions
(from sponsor)		 DVT - Deep Vein Thrombosis
Related terms Venous Thrombosis
Enrollment 112 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov